Logo image of ANTX

AN2 THERAPEUTICS INC (ANTX) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:ANTX - US0373261058 - Common Stock

1.06 USD
-0.04 (-3.64%)
Last: 11/26/2025, 8:15:41 PM
1.0699 USD
+0.01 (+0.93%)
After Hours: 11/26/2025, 8:15:41 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to ANTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.53. This target is 44.34% above the current price.
ANTX was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ANTX.
In the previous month the buy percentage consensus was at a similar level.
ANTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
ANTX Historical Analyst RatingsANTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -42 -38 -34 -30 -26 -22 -18 -14 -10 -6 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.061.011.531.532.10 - -4.72% 44.34% 44.34% 98.11%
ANTX Current Analyst RatingANTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-05-05 JMP Securities Maintains Market Outperform -> Market Outperform
2025-03-26 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-02-25 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2025-02-03 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-11-19 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-11-18 TD Cowen Downgrade Buy -> Hold
2024-08-09 JMP Securities Maintains Market Outperform -> Market Outperform
2024-07-03 Leerink Partners Upgrade Market Perform -> Outperform
2024-05-16 Evercore ISI Group Maintains In-Line -> In-Line
2024-04-02 JMP Securities Upgrade Market Perform -> Market Outperform
2024-04-01 Oppenheimer Reiterate Perform -> Perform
2024-02-13 Leerink Partners Downgrade Outperform -> Market Perform
2024-02-12 JMP Securities Downgrade Market Outperform -> Market Perform
2024-02-12 Oppenheimer Downgrade Outperform -> Perform
2024-02-12 Evercore ISI Group Downgrade Outperform -> In-Line
2024-01-04 JMP Securities Initiate Market Outperform
2023-03-30 Oppenheimer Maintains Outperform
2022-11-14 SVB Leerink Maintains Outperform
2022-04-19 Oppenheimer Initiate Outperform
2022-04-19 Cowen & Co. Initiate Outperform
2022-04-19 Evercore ISI Group Initiate Outperform

AN2 THERAPEUTICS INC / ANTX FAQ

What is the price target for ANTX stock?

8 analysts have analysed ANTX and the average price target is 1.53 USD. This implies a price increase of 44.34% is expected in the next year compared to the current price of 1.06.


How do analysts rate AN2 THERAPEUTICS INC (ANTX)?

The consensus rating for AN2 THERAPEUTICS INC (ANTX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.